Bangladesh vs Haiti: Death rate from cancer
Bangladesh
67.27 deaths per 100,000 people
in 2021
Haiti
66.67 deaths per 100,000 people
in 2021
Bangladesh rank
125th
Haiti rank
126th
Death rate from cancer over time
- Bangladesh
- Haiti
How they compare
Bangladesh currently reports 67.27 deaths per 100,000 people against 66.67 deaths per 100,000 people in Haiti, a difference of 0.6 deaths per 100,000 people.
The two have swapped places 1 time across 22 shared years of data; in 2000 it was Haiti ahead.
Bangladesh ranks 125th and Haiti ranks 126th of 194 countries.
Haiti has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bangladesh | Haiti | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 62.34 deaths per 100,000 people | 70.71 deaths per 100,000 people | 8.37 deaths per 100,000 people | Haiti |
| 2010s | 64.89 deaths per 100,000 people | 74.51 deaths per 100,000 people | 9.62 deaths per 100,000 people | Haiti |
| 2020s | 65.75 deaths per 100,000 people | 68.42 deaths per 100,000 people | 2.67 deaths per 100,000 people | Haiti |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher death rate from cancer, Bangladesh or Haiti?
- Bangladesh, at 67.27 deaths per 100,000 people against 66.67 deaths per 100,000 people in Haiti as of 2021.
- What is the difference in death rate from cancer between Bangladesh and Haiti?
- 0.6 deaths per 100,000 people, with Bangladesh ahead.
- How many years of comparable data are there for Bangladesh and Haiti?
- 22 years are reported by both, from 2000 to 2021.
- How do Bangladesh and Haiti rank globally for death rate from cancer?
- Bangladesh ranks 125th and Haiti ranks 126th of 194 countries.
- Where does this data come from?
- World Health Organization (2024) – with major processing by Our World in Data, published as Death rate from cancer. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from malignant neoplasms in both sexes, per 100,000 people.